Ghrelin-immunoreactive cells in the gastrointestinal tract of hypertensive rats

The amount of ghrelin-immunoreactive cells in the abomasum and intestines of 13-14-week-old calves supplemented with Jerusalem artichoke flour alone or in combination with Saccharomyces cerevisiae yeast

Background and Aim: The use of antibiotics in animals for disease prevention and productivity has been banned in the European Union since 2006. Possible alternatives can be used prebiotics, probiotics, and synbiotics. These compounds can improve feed digestion and absorption in the gastrointestinal tract with identical nutrient uptake, while imparting the feeling of satiety, which reduces the activity of ghrelin-immunoreactive (IR) cells. The number of studies performed on the activity of ghrelin-IR cells in ruminants is insufficient. In particular, there are few such studies in calves during the transition period from being a relatively monogastric animal to a ruminant. The present study aimed to evaluate the effect of Jerusalem artichoke flour (containing ∼50% prebiotic inulin) and a new, commercially unavailable synbiotic (combination of Jerusalem artichoke flour and Saccharomyces cerevisiae strain 1026) on the amount of ghrelin-IR cells in the abomasum and intestines of 13-14-week-old calves. Materials and Methods: Fifteen crossbreed, Holstein Friesian and Red Holstein calves (Bos taurus) (32±4 days, 72.1±11.34 kg) were used. Calves were allocated into three groups: Control group (CoG, n=5) received the standard diet, prebiotic group (PreG, n=5) received 12 g of flour of Jerusalem artichoke (Helianthus tuberosus) per head containing 6 g of prebiotic inulin in addition to the standard diet, and synbiotic group (SynG, n=5) received a synbiotic in addition to the standard diet which consisted of two different products: 12 g of flour of Jerusalem artichoke per head containing 6 g of prebiotic inulin and probiotic 5 g of a yeast S. cerevisiae strain 1026. Feed additives were added to the concentrate once a day for 56 days. On days 1, 28, and 56, the live weight of the calves was determined. On day 56 of the experiment, three calves from each group were slaughtered. Histological samples were collected from the two parts of each calf abomasum: Pars pylorica and pars fundalis and the middle part of the duodenum and jejunum. Immunohistochemical tissue staining methods were used to detect ghrelin-IR cells. Results: The live weight of the slaughtered calves on day 56 was 115.3±21.73 kg in CoG, 130.0±17.32 kg in PreG, and 119.0±7.94 kg in SynG. Ghrelin-IR cells were more abundantly localized in the cytoplasm of the abomasum muscle gland cells in pars fundalis and pars pylorica, and to a lesser extent in the duodenum and jejunum. The number of ghrelin-IR cells in the abomasal fundic gland area was significantly higher in the CoG, than in the PreG and SynG (p=0.0001), while the difference between the PreG and SynG was not significant (p=0.700). Conclusion: The addition of Jerusalem artichoke flour and its combination with the yeast S.cerevisiae stain 1026 in calves resulted in a lower number of ghrelin-IR cells in the abomasum, duodenum, and jejunum and, although insignificantly, increased live weight (p=0.491), suggesting that calves in these groups with the same feed intake as the CoG had a better breakdown of nutrients, thus having a longer feeling of satiety.

Ghrelin regulates sepsis‑induced rat acute gastric injury

Ghrelin, a peptide expressed in the gastric mucosa, has an essential role in sustaining the normal function of the digestive system. Sepsis is one of the primary causes of mortality in intensive care units and can lead to multiple organ dysfunction, especially in the gastrointestinal system. The aim of the present study was to explore the effect of ghrelin on gastric blood flow in a rat model of sepsis, as well as the effect of ghrelin on the expression of the apoptotic markers, B-cell lymphoma 2 (Bcl-2) and Bcl-2-associated X (Bax), in gastric tissues. The sepsis model was established using cecal ligation and puncture (CLP). The expression levels of apoptosis-related factors in gastric epithelial cell were determined by immunohistochemistry, reverse transcription quantitative-PCR and western blotting. Collectively, the present results suggested that ghrelin administration attenuated sepsis symptoms induced by CLP. Blood flow in the stomach greater curvature was significantly higher in the CLP-induced sepsis group rats (284.3±95.7 perfusion units) compared with the sham operation group (317.8±5.2 perfusion units; P<0.05), whereas there was no difference between the CLP group treated with ghrelin (377.8±99.0 perfusion units) and the sham rats. Ghrelin administration also reduced the secretion of pro-inflammatory cytokines compared with the CLP-induced sepsis group rats. In addition, CLP significantly reduced the expression of Bcl-2 and enhanced the expression of the pro-apoptotic proteins, Bax and cleaved caspase-3; whereas, ghrelin application reversed the effects of CLP on these apoptosis-associated proteins. In conclusion, the present study revealed that ghrelin has the ability to increase blood flow in the gastrointestinal tract in a sepsis model and can also regulate the expressions of apoptosis-associated factors in gastric tissues. These results suggest that ghrelin could be a novel treatment for sepsis-induced gastric injury.